Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Journal of Gastrointestinal Oncology|April 2, 2016
Neoadjuvant chemoradiation followed by orthotopic liver transplantation in cholangiocarcinomas: the emory experienceEdward M Marchan, Jerome C LandryJournal of the National Medical Association|June 25, 2002
Breast conservation is an effective option in Black, medically indigent patientsStuart H Burri, Jerome C Landry, Lawrence W DavisJournal of the National Medical Association|July 16, 2004
Black and white patients fare equally well when treated with postlumpectomy radiotherapyStuart H Burri, Jerome C Landry, H James Norton, et al.The Oncologist|March 30, 2004
Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approachesMary Koshy, Natia Esiashvilli, Jerome C Landry, et al.The Oncologist|March 30, 2004
Multiple management modalities in esophageal cancer: combined modality management approachesMary Koshy, Natia Esiashvilli, Jerome C Landry, et al.Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|December 23, 2011
Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for pancreatic malignanciesArif N Ali, Anees H Dhabaan, Christie S Jarrio, et al.Journal of Gastrointestinal Oncology|November 30, 2017
Adaptive radiation dose escalation in rectal adenocarcinoma: a reviewJonathan D Van Wickle, Eric S Paulson, Jerome C Landry, et al.World Journal of Gastrointestinal Oncology|April 21, 2016
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomasCrystal S Seldon, Lauren E Colbert, William A Hall, et al.Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 21, 2002
Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicityJerome C Landry, Gary Y Yang, Joseph Y Ting, et al.International Journal of Cancer|February 26, 2019
Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancerGanji Purnachandra Nagaraju, Katerina M Zakka, Jerome C Landry, et al.Pageof 4